CD30:CD30L may not affect APC function in atherosclerosis, as anti-CD30L treatment did not change BC counts, ox-LDL-specific IgM/IgG, and aortic MC numbers in LDLR−/− mice [100]. This evidence concerns the gene TNFRSF8 and atherosclerosis.